Kyphon gains FAD (functional anaesthetic discography) system with InnoSpine buy
This article was originally published in Clinica
Developer of minimally-invasive technologies for restoring spinal function Kyphon is to acquire a privately-held company specialising in back pain devices in a transaction that could be worth over $30m. Sunnyvale, California-based Kyphon definitively agreed to make an upfront payment of $2.5m for InnoSpine, together with the possibility of an additional $27.5m in cash or stock - based on achievement of clinical and other milestones - and undisclosed royalties on future net sales. The transaction is expected to close this month.